戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ulated by activating transcription factor 4 (ATF4).
2 , such as activating transcription factor 4 (ATF4).
3 t involve activating transcription factor 4 (ATF4).
4 lpha) and activating transcription factor 4 (ATF4).
5 including activating transcription factor 4 (ATF4).
6 on of the Activating Transcription Factor 4 (ATF4).
7 lation of activating transcription factor 4 (Atf4).
8 diated by the transcription factors CHOP and ATF4.
9 esses, but induces specific proteins such as ATF4.
10 expression of GADD34, a downstream target of ATF4.
11 DAC4 in the nucleus and its association with ATF4.
12  proteins including the transcription factor ATF4.
13 2alpha and promotes XIAP degradation through ATF4.
14 tion of DISC1 with the PDE4D9 locus requires ATF4.
15 silencing blocked the protective capacity of ATF4.
16 iation, and down-regulates the expression of ATF4.
17 of ATF5 is directly induced by both CHOP and ATF4.
18 ed translation of specific messages, such as ATF4.
19 itically depends on the transcription factor Atf4.
20 e coding variation in the eIF2alpha effector ATF4.
21 ession of activating transcription factor 4 (ATF4), a master transcription factor for stress-induced
22 hown that activating transcription factor 4 (ATF4), a master transcriptional effector of the ISR, pro
23 sm by the activating transcription factor 4 (ATF4), a member of the basic leucine zipper-containing p
24 he ISR is activating transcription factor 4 (ATF4), a transcription factor that regulates genes invol
25 criptome analysis demonstrated activation of ATF4, a key transcription factor in the integrated stres
26                                              ATF4, a key transcription mediator of the integrated str
27  coincident with preferential translation of ATF4, a transcriptional activator of the integrated stre
28                     Upon loss of attachment, ATF4 activated a coordinated program of cytoprotective a
29                                     Instead, ATF4 activates the expression of cytoprotective genes, w
30                     The transcription factor ATF4 (activating transcription factor 4) is induced by m
31 al agents and/or lead compounds for reducing ATF4 activity, weakness, and atrophy in aged skeletal mu
32  expression of negative transcription factor ATF4 (aka CREB2) both in human and a mouse model express
33 st development by upregulating the levels of ATF4, ALP and RUNX2, and it stimulated angiogenesis of e
34 A rescue of AAR activation in the absence of Atf4 also occurred for the Atf3 and C/EBP homology prote
35 SC1 inhibits the transcriptional activity of ATF4, an effect that is weakened by both 37W and 607F in
36  the CHAC1 ATF/CRE and ACM sequences to bind ATF4 and ATF3 using immunoblot-EMSA and confirmed ATF4,
37  with the bZIP domains from human JUN, XBP1, ATF4 and ATF5.
38 pression of activating transcription factors ATF4 and ATF6.
39 ess, the UPR-activated transcription factors ATF4 and ATF6alpha transcriptionally up-regulate Zip14 e
40 nse, manifested by enhanced transcription of ATF4 and C/EBP homologous protein.
41 on, together with corresponding decreases in ATF4 and CAAT/enhancer binding protein homologous protei
42 ctivated the unfolded protein response, both ATF4 and CHOP activation were diminished in Bok(-/-) cel
43 m induction of the UPR transcription factors ATF4 and CHOP by a mechanism involving increased express
44                         Forced expression of ATF4 and CHOP protein before UVB irradiation significant
45 s, UPR proteins (GRP78, p-PERK, p-eIF2alpha, ATF4 and CHOP) and apoptosis were observed in PAO-treate
46 d the induction of UPR transcription factors ATF4 and CHOP, suggesting that the UPR could be targeted
47 hdrawal induced the stress response proteins ATF4 and CHOP/GADD153; however, LPS stimulation rapidly
48 rib3 is induced by the transcription factors ATF4 and CHOP; and downstream, Trib3 interferes with the
49 ng associated with increased p-eIF2alpha and ATF4 and decreased sXBP1 and CHOP.
50 bility of glucagon plus insulin to stimulate ATF4 and FGF21 expression.
51 imicked the ability of glucagon to stimulate ATF4 and FGF21 expression.
52 aling activity suppressed CDCA regulation of ATF4 and FGF21 expression.
53  resistance and tumor metastasis and suggest ATF4 and HO-1 as potential targets for therapeutic inter
54       Meanwhile, the increased expression of ATF4 and HO-1 mRNAs were observed in lesions derived fro
55 thways dependent on the transcription factor ATF4 and identified nuclear protein transcriptional regu
56 kers with COPD that may be driven in part by ATF4 and is modifiable with therapy.
57 ncrease in the transcriptional activation of ATF4 and NFATc1 genes.
58  Here, we show that UPR induces Sestrin2 via ATF4 and NRF2 transcription factors and demonstrate that
59 tarvation induces SLC7A11 expression through ATF4 and NRF2 transcription factors and, correspondingly
60 ucing direct transcriptional upregulation of ATF4 and other UPR genes.
61 echanisms by which HIF1alpha intersects with ATF4 and p53 pathways.
62  Loss of HIF1alpha resulted in activation of ATF4 and p53, the latter inhibiting CM proliferation.
63 n addition, activation of the GCN2-eIF2alpha-ATF4 and PERK-eIF2alpha-ATF4 signaling pathways are resp
64 ssion of eIF5 and 5MP induces translation of ATF4 and potentially other genes with uORFs in their mRN
65  protein response, with increases in Bip and ATF4 and reductions in spliced Xbp1 mRNA.
66          Despite this, a direct link between ATF4 and the degree of proliferative retinopathy has not
67 was the result of simultaneous activation of ATF4 and the transcription factor NRF2, which converged
68 nesis of endothelial cells through elevating ATF4 and VEGF.
69                   We induced OIR in C57BL/6, ATF4(+/-), and endoplasmic reticulum stress-activated in
70  signals, activating transcription factor 4 (ATF4) and ATF6 indicating potential contributions of the
71 , such as activating transcription factor 4 (ATF4) and C/EBP-homologous protein (CHOP), that serve to
72 n of both activating transcription factor 4 (ATF4) and CHOP (DDIT3), critical regulators of the pathw
73 lation of activating transcription factor 4 (ATF4) and is a crucial evolutionarily conserved adaptive
74 ession of activating transcription factor 4 (ATF4), and cleavage of ATF6 were significantly increased
75 f cell stress pathways, including HIF1alpha, ATF4, and p53, are key to normal development and play cr
76 ing and a complex interplay among HIF1alpha, ATF4, and p53.
77 steoblastic markers (Runx2,Col1a1,Bglap2,Sp7,Atf4, andAlpl).
78                    Furthermore, both 5MP and ATF4 are essential for larval development.
79  for the first time that both eIF2alphaP and ATF4 are necessary to promote erythroid differentiation
80 we show that the activation of the eIF2alpha/ATF4 arm of the unfolded protein response is sufficient
81 c-Myc and N-Myc activated the PERK/eIF2alpha/ATF4 arm of the UPR, leading to increased cell survival
82                      These results elucidate ATF4 as a critical mediator of age-related muscle weakne
83 ranslation in neurodegeneration and identify ATF4 as a mediator for the spread of AD pathology.
84       Based on this finding, we investigated ATF4 as a potential mediator of age-related muscle weakn
85                          Our study validates ATF4 as a prospective therapeutic target to inhibit neov
86 alpha, is a direct transcriptional target of ATF4 as is shown in ChIP assays.
87 dentified activating transcription factor 4 (ATF4) as a potential transcriptional regulator of genes
88  identify activating transcription factor 4 (ATF4) as the main regulator of the stress response.
89 1 (Nupr1), a stress response gene induced by ATF4, as the gene most strongly upregulated.
90                               C/EBPgamma and ATF4 associate with genomic CAREs in a mutually dependen
91 hysically interacted with and phosphorylated ATF4 at tyrosine and threonine residues.
92 ression of vimentin, a negative regulator of ATF4, at the post-transcriptional level.
93 and ATF3 using immunoblot-EMSA and confirmed ATF4, ATF3, and CCAAT/enhancer-binding protein beta bind
94 by translation initiation inhibition and the ATF4/ATF3 pathway, and U bodies rapidly disappeared upon
95 In this study, we identify a novel DISC1 and ATF4 binding region in the genomic locus of phosphodiest
96                                    Increased Atf4 binding regulated the association of elongation fac
97 ed by two activating transcription factor 4 (ATF4) binding sites in the FGF21 gene.
98 ds to rapid expression of genes regulated by ATF4-binding cis elements.
99 PH oxidase-4 (Nox4) is induced downstream of ATF4, binds to a PP1-targeting subunit GADD34 at the end
100                                  Upstream of Atf4, BMP2 activates mTORC1 to stimulate protein synthes
101 eoblast differentiation genes osterix (Sp7), Atf4, bone sialoprotein (Ibsp), and osteocalcin (Bglap)
102 nce of unfolded protein response activation, ATF4 bound to the human VEGFA promoter and activated its
103 sulted from activation of the GCN2/eIF2alpha/ATF4 branch of the ISR pathway.
104 escued by an shATF4-resistant active form of ATF4, but not by a mutant that lacks transcriptional act
105 ver, for those genes with a downstream CARE, Atf4, C/ebp-homology protein (Chop), Pol II and TATA-bin
106 of SM hydrolysis partially protected against ATF4/C/EBP homology protein induction because of palmita
107       In this report, we further defined the ATF4-CHAC1 interaction by cloning the human CHAC1 promot
108 tion of unfolded protein response components ATF4, CHOP, GRP78, and XBP1 in CP.
109  a UPR effector signaling involving the PERK-ATF4-CHOP pathway, upregulation of the proapoptotic cell
110 K (protein kinase-like kinase) and eIF2alpha-ATF4-CHOP signaling.
111 hese findings indicate that the induction of ATF4/CHOP expression occurs via mTORC1 regulation of c-M
112 IF2alpha and thereby inhibit the p-eIF2alpha/ATF4/CHOP pro-apoptotic pathway, identifying miR-30b-5p
113  under ER stress, suppresses the p-eIF2alpha/ATF4/CHOP pro-apoptotic pathway.
114 anscription under conditions of ER stress or ATF4 coexpression: the -267 ATF/cAMP response element (C
115   Finally, 5MP and the paired uORFs allowing ATF4 control are conserved in the entire metazoa except
116                           Here, we show that ATF4 controls a hepatic gene expression profile that ove
117  coincident with preferential translation of ATF4 (CREB2).
118                                Knocking down ATF4 decreased NRF2 expression and its nuclear transloca
119 ctive of this study was to determine whether ATF4 deficiency could reduce neovascularization in mice
120 reconstitution of ATF4 or HO-1 expression in ATF4-deficient cells blocked anoikis and rescued tumor l
121                                              ATF4-deficient human fibrosarcoma cells were unable to c
122                                     In naive ATF4-deficient mice, we also observed an elevation in UP
123  kinase activity was required to inhibit the ATF4-dependent activation of the NOXA gene because the s
124 hese results establish HO-1 as a mediator of ATF4-dependent anoikis resistance and tumor metastasis a
125 ted adaptation and induces apoptosis through ATF4-dependent expression of pro-apoptotic factors inclu
126 ng intermediate filament protein, suppresses ATF4-dependent osteocalcin (Ocn) transcription and osteo
127                Inhibition of FASN induced an ATF4-dependent transcriptional induction of REDD1; downr
128 tryptophan 2,3-dioxygenase (TDO) resulted in ATF4-dependent upregulation of several amino acid transp
129 -transformed cells induces apoptosis through ATF4-dependent, but p53-independent, PUMA and NOXA induc
130                                              ATF4 depletion decreases both cell-density-dependent tra
131                                              ATF4 depletion preferentially attenuated hepatic lipogen
132 nto the underlying mechanism, we showed that ATF4 depletion resulted in a significant reduction in he
133 BPgamma:ATF4 heterodimers, but not C/EBPbeta:ATF4 dimers, are the predominant CARE-binding species in
134      Protein pull-down assays indicated that Atf4 directly interacts with CDK9 and its associated pro
135           In earlier studies, we showed that ATF4 down-regulation affects post-synaptic development a
136                           Here, we find that ATF4 down-regulation in both hippocampal and cortical ne
137  screen showed that the transcription factor ATF4 drives ULBP1 gene expression in cancer cell lines,
138 nd phosphorylation-dependent inactivation of ATF4 during the pathogenesis of medullary thyroid cancer
139         In neuronal PC12 cells, silencing of ATF4 enhanced cell death in response to either 6-OHDA or
140 eby promoting translation of GCN4, the yeast ATF4 equivalent.
141 nase/activating transcription factor 4 (PERK/ATF4) ER stress pathway, innate immune mediators, and in
142 knockdown of 5MP1 in fibrosarcoma attenuates ATF4 expression and its tumor formation on nude mice.
143 increases FGF21 transcription by stimulating ATF4 expression and that activation of cAMP/PKA and PI3K
144 lic acid (CDCA) induced a 6-fold increase in ATF4 expression and that knockdown of ATF4 expression su
145 mycin to prevent bortezomib-induced CHOP and ATF4 expression as well as apoptosis.
146 R can induce tumor cell death, modulators of ATF4 expression could prove to be clinically useful.
147 and 5MP2, the second human paralog, promotes ATF4 expression in certain types of human cells includin
148              5MP overexpression also induces ATF4 expression in Drosophila The knockdown of 5MP1 in f
149  supporting a role for Fh1 in the control of Atf4 expression in mammals.
150 PKRi) demonstrate a significant reduction in ATF4 expression levels 3 h after one injection of PKRi.
151                        Knocking down PERK or ATF4 expression or inhibiting PERK kinase activity dimin
152 that a targeted reduction in skeletal muscle ATF4 expression reduces age-related deficits in skeletal
153 ase in ATF4 expression and that knockdown of ATF4 expression suppressed the ability of CDCA to increa
154  in ATF4 protein abundance, and knockdown of ATF4 expression suppressed the ability of glucagon plus
155 tain ApoB100 protein levels independently of Atf4 expression, whereas hydrogen sulfide production is
156 ction of GCN2/eIF2alpha phosphorylation, and ATF4 expression, which overrides PERK/Akt-mediated adapt
157 iates the effect of glucagon plus insulin on ATF4 expression.
158 2alpha phosphorylation, dramatically delayed ATF4 expression.
159 al libraries were screened for modulators of ATF4 expression.
160 tially by an eIF2alpha-dependent increase in ATF4 expression.
161 onally to activating transcription factor 4 (ATF4) following treatment with oxidized phospholipids, a
162  and reveals a requirement for expression of ATF4 for expression of genes involved in oxidative stres
163 ied transcription factor for PTH and through ATF4 for the sympathetic tone.
164 pression and phosphorylation of Sestrin2, an ATF4 gene target, was increased by asparaginase, suggest
165 tectable effect upon stress-induced SNAT2 or ATF4 gene transcription, the associated increase in SNAT
166 crease in activating transcription factor 4 (ATF4) has been previously reported in the diabetic retin
167                Here, we show that C/EBPgamma:ATF4 heterodimers, but not C/EBPbeta:ATF4 dimers, are th
168 ctedly, without translation reprogramming an ATF4-high/MITF-low state is insufficient to drive invasi
169 es the ER stress markers CHOP, GADD45, EDEM, ATF4, Hsp90, ATG5, and phospho-eIF2alpha.
170                       To explore the role of ATF4 in cell survival in PD-relevant contexts, we either
171 ontexts, we either silenced or overexpressed ATF4 in cellular models of PD.
172                  Overexpression of GRP78 and ATF4 in human CP confirmed the experimental findings.
173 hospho-eIF2alpha independent upregulation of ATF4 in order to maintain ISR signaling, indicating that
174 otherapy, transcriptionally repress MITF via ATF4 in response to inhibition of translation initiation
175                         However, the role of ATF4 in the pathogenesis of PD has not been explored.
176 ositioned Atf5 downstream of and parallel to Atf4 in the regulation of eIF4E-binding protein 1 (4ebp1
177 ISR and dose-dependently increased levels of ATF4 in transformed cells.
178 e role of activating transcription factor 4 (ATF4) in controlling the hepatic transcriptome and media
179 ression of ER stress markers such as Bip and Atf4, increased bone growth, and reduced skeletal dyspla
180 that the loss of function of either DISC1 or ATF4 increases PDE4D9 transcription, and that the associ
181 eated with tyrosine kinase inhibitors or the ATF4 inducer eeyarestatin as well as in RET-depleted TT
182                      We showed recently that ATF4 induces an anabolic program through the up-regulati
183                           In cultured cells, ATF4 induces transcriptional expression of genes directe
184 rylation, activating transcription factor-4 (ATF4) induction, and increased expression of known downs
185  did not directly regulate the expression of ATF4; instead, it enhanced the expression of vimentin, a
186  proteins, including GRP78, PERK, eIF2alpha, ATF4, IRE1alpha, JNK, p38, and CHOP.
187                                              ATF4 is a pro-oncogenic transcription factor whose trans
188                                              ATF4 is a transcriptional activator of the integrated st
189  and show in liver exposed to ER stress that ATF4 is not required for CHOP expression, but instead AT
190              RNA-Seq analysis indicates that ATF4 is responsible for a small portion of the PERK-depe
191 eostasis, activating transcription factor 4 (ATF4), is dysfunctional in HD because of oxidative stres
192 t Atf5, a close but less-studied relative of Atf4, is also a target of Pdx1 and is critical for beta-
193 IF2alphaP-activating transcription factor 4 (ATF4) ISR in primary erythroid precursors to combat oxid
194  six activator protein 1 (AP-1) transcripts (ATF4,JUNB,JUN,FOSB,FOS, andJUND) were up-regulated at d9
195     Induction of gamma-H2AX was abrogated in ATF4 knockdown cells.
196  characterize whole-body and tissue-specific ATF4-knockout mice and show in liver exposed to ER stres
197                                              ATF4 levels are also upregulated in neuronal PC12 cells
198                                 We find that ATF4 levels are increased in neuromelanin-positive neuro
199 marked decreases in p-PERK, p-eIF2alpha, and ATF4 levels but robust increases in GRP78 protein levels
200 ases eIF2alpha phosphorylation and HSP90 and ATF4 levels, and limits the accumulation of soluble Abet
201 lated kinase) phosphorylation, and HSP90 and ATF4 levels.
202 ty to increase eIF2alpha phosphorylation and ATF4 levels.
203  revealed DNA copy number alterations at the ATF4 locus, an important activator of the UPR/AAR pathwa
204                                              ATF4 may exert either protective or deleterious effects
205 pending on the extent of protein disruption, ATF4 may not be able to restore proteostatic control and
206 that mitochondrial DNA depletion leads to an ATF4-mediated increase in serine biosynthesis and transs
207 somal recessive PD, plays a critical role in ATF4-mediated protection.
208 pertonicity by a mechanism dependent on both ATF4-mediated transcription of the SLC38A2 gene and enha
209 etase genes downstream of the stress-induced ATF4-mediated transcription program.
210                    Livers from Atf4 (-/-) or Atf4 (+/-) mice displayed an amplification of the amino
211 r explored selected responses in livers from Atf4 (+/-) mice.
212 rns in livers from wildtype, Gcn2 (-/-), and Atf4 (-/-) mice treated with asparaginase or excipient a
213  in hepatic mTORC1 signaling was retained in Atf4 (-/-) mice treated with asparaginase.
214 ective erythropoiesis of Hri(-/-) , eAA, and Atf4(-/-) mice by inhibiting both HRI and mTORC1 signali
215 ffect of ATF4 on hepatic lipid metabolism in Atf4(-/-) mice fed regular chow or provided with free ac
216    Of particular significance, we found that Atf4(-/-) mice, as opposed to wild-type littermates, wer
217 d excessive fat accumulation in the liver of Atf4(-/-) mice, when compared with wild-type littermates
218 ee key functions in the lipogenic pathway in Atf4(-/-) mice.
219  retrograde transport or knockdown of axonal Atf4 mRNA abolished Abeta-induced ATF4 transcriptional a
220 globin synthesis and enhances translation of ATF4 mRNA in mouse beta-thalassemic erythroid precursors
221 tor rescued memory impairment and attenuated ATF4 mRNA increased expression in the ApoE4 mice.
222 tionale for this discordant response is that ATF4 mRNA is reduced by UVB, and despite its ability to
223                      Significance statement: ATF4 mRNA relative quantities are elevated in ApoE4 alle
224                        Protein synthesis and Atf4 mRNA were upregulated in these axons, and coinjecti
225 bles translation of the transcription factor ATF4 mRNA.
226 lation of activating transcription factor 4 (ATF4) mRNA to induce stress response genes.
227 ced body size and microphthalmia, similar to ATF4-null animals.
228 tin immunoprecipitation assays revealed that ATF4 occupancy increased at the NOXA promoter in TT cell
229                  We determined the effect of ATF4 on hepatic lipid metabolism in Atf4(-/-) mice fed r
230                       However, expression of ATF4 or CHOP was not induced by UVB as compared with tra
231 for the UPR-associated transcription factors Atf4 or Chop were significantly protected from CNT, impl
232 ngs in a murine model, and reconstitution of ATF4 or HO-1 expression in ATF4-deficient cells blocked
233 scription factors and, correspondingly, that ATF4 or NRF2 deficiency also renders cancer cells more r
234                                  Livers from Atf4 (-/-) or Atf4 (+/-) mice displayed an amplification
235 t that inhibition of PKR is a way to restore ATF4 overexpression and memory impairment in early stage
236  with COPD-associated airway expression, and ATF4 overexpression in airway epithelial cells in vitro
237 e toxin-induced reduction of parkin, whereas ATF4 overexpression partially preserves parkin levels.
238 ovel antioxidant regulator and an obligatory ATF4 partner that controls redox homeostasis in normal a
239 e independent of the well characterized GCN2-ATF4 pathway and instead dependent on MEK-ERK signaling,
240 ith mitochondrial diseases, we show that the ATF4 pathway is activated in vivo upon mitochondrial str
241              Furthermore, the HRI-eIF2alphaP-ATF4 pathway suppresses mTORC1 signaling specifically in
242 ER stress, triggering activation of the PERK-ATF4 pathway, which potentially contributes to the lens
243 ogen sulfide production is promoted via GCN2-ATF4 pathway.
244 ta/delta and activation of the HRI-eIF2alpha-ATF4 pathway.
245  other things, an activation of the Nrf2 and ATF4 pathways.
246                  These data demonstrate that ATF4 plays a critical role in regulating hepatic lipid m
247                  These results indicate that ATF4 plays a protective role in PD through the regulatio
248              c-MYC subsequently bound to the ATF4 promoter, suggesting direct involvement of an mTORC
249 plus insulin stimulated a 5-fold increase in ATF4 protein abundance, and knockdown of ATF4 expression
250                                              ATF4 protein and transcripts were found with greater fre
251 that eIF2alphaP is required for induction of ATF4 protein synthesis in vivo in erythroid cells during
252                Conversely, overexpression of ATF4 reduced cell death caused by dopaminergic neuronal
253 s seen in an impairment of cell migration on ATF4 reduction in non-neuronal cells.
254 e identified a new cellular pathway in which ATF4 regulates the expression of RhoGDIalpha that in tur
255  phylogenetic and functional linkage between ATF4 regulation and 5MP expression in this group of euka
256 SCs and a novel cell-free assay reveals that ATF4 requires C/EBPbeta for genomic binding at a motif d
257 dant supplementation reverses the disordered ATF4 response to nutrient stress.
258 ith this pattern of gene expression, loss of ATF4 resulted in enhanced oxidative damage, and increase
259                                      The OIR ATF4(+/-) retinas demonstrated reprogramming of the UPR
260 ia-driven neovascularization in experimental ATF4(+/-) retinas.
261 rapidly phosphorylated Erk, and up-regulated Atf4, Runx2, Osx, Lrp5, beta-catenin, Alp, and Col1a1; t
262                                     GCN2 and ATF4 serve complementary roles in the hepatic response t
263 it inflammation and mTORC1 signaling whereas ATF4 serves to limit the amino acid response and prevent
264 asparaginase exposure is not driven via eIF2-ATF4-Sestrin2.
265 g hepatic activating transcription factor 4 (Atf4) showed an exaggerated ISR and greater loss of endo
266         We propose that the PERK/eIF2alpha-P/ATF4 signaling acts as a brake in the decline of protein
267       We report here that the PERK/eIF2alpha/ATF4 signaling branch of the integrated endoplasmic reti
268 heme deficiency in vivo, this HRI-eIF2alphaP-ATF4 signaling is necessary both to reduce oxidative str
269 f the GCN2-eIF2alpha-ATF4 and PERK-eIF2alpha-ATF4 signaling pathways are responsible for increased PE
270 lator of this response is the PERK/eIF2alpha/ATF4 signaling where eIF2alpha is phosphorylated (eIF2al
271 eIF2alpha/activating transcription factor 4 (ATF4) signaling module.
272 ession through an AKT-independent, PDK1-RSK2-ATF4 signalling axis.
273 and human tumor cell lines, and knockdown of ATF4 significantly increased the antiproliferative effec
274 (PERK) or activating transcription factor 4 (ATF4) significantly reduced the production of angiogenes
275 on of the transcription factor XBP1, but not ATF4, significantly delay locomotor recovery.
276                                              ATF4 silencing exacerbates the toxin-induced reduction o
277 regulated in these axons, and coinjection of Atf4 siRNA into the DG reduced the effects of Abeta1-42
278 ranscriptional regulators, including NFE2L2, ATF4, Srebf1 and Rictor were identified as potential key
279 at block threonine phosphorylation increased ATF4 stability and activated its targets NOXA and PUMA.
280                               HRI-eIF2alphaP-ATF4 stress signaling is important not only to inhibit e
281 ption factors like C/EBPbeta, C/EBPdelta and ATF4 that have G/C rich or uORF sequences in their 5' UT
282 , primarily by the bZIP transcription factor ATF4 through its recruitment to cis-regulatory C/EBP:ATF
283 ranslational control of transcription factor ATF4 through paired upstream ORFs (uORFs) plays an impor
284 er recruitment of the bZip TFs C/EBPbeta and ATF4 to a non-canonical C/EBP DNA sequence.
285 ous amino acids, activated GCN2 up-regulates ATF4 to induce expression of the stress response protein
286 tiation of a transcriptional program through ATF4 to promote recovery from nutrient deprivation.
287 r characterize the interaction of DISC1 with ATF4 to show that it is regulated via protein kinase A-m
288 esis enzyme genes PHGDH, PSAT1 and SHMT2 via ATF4 to support glutathione and nucleotide production.
289  of axonal Atf4 mRNA abolished Abeta-induced ATF4 transcriptional activity and cell loss.
290 lly induced by phosphorylation of eIF2alpha, ATF4 translation can be also induced by expression of a
291 lammation-mediated hepatic processes whereas ATF4 uniquely associates with cholesterol metabolism and
292 nduced by activating transcription factor 4 (Atf4) via C/ebp-Atf-Response-Element (CARE) enhancers.
293                                              ATF4 was also protective against 6-OHDA-induced death of
294                                              ATF4 was further demonstrated to bind directly to cis-re
295                                              ATF4 was not translated during hyperosmotic stress despi
296                                    Levels of ATF4 were similar in wild type and heterozygous lenses b
297 ession of activating transcription factor 4 (Atf4), which indicates the activation of oxidative stres
298 on factor Activating Transcription Factor 4 (ATF4), which is involved in the regulation of cellular s
299 ulated by activating transcription factor 4 (ATF4), which was activated by mTORC1 independent of its
300 e AAR and UPR lead to increased synthesis of ATF4, which mediates PCK2 transcriptional up-regulation

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top